BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory


Emulate logo


Founded in 2013, Emulate is a Boston-based company developing organ-on-a-chip systems for various research and drug discovery purposes. By now, they raised a total $224.3M from multiple investors, with the last $82M Series E round led by Northpond Ventures.
Emulate has multiple organ-on-a-chips in their portfolio, specializing on a deeper understanding of the organ function itself, rather than the complex interplay of multiple organs. With the chips for kidney, liver, lung, brain and more, the company claims to effectively predict toxicology profiles or inflammatory responses for the patients. For example, the brain chip contains 5 cell types, forming the human neuro-vascular unit model, which is representative for the blood-brain barrier, cell microenvironment and multicellular diversity.

Posts Mentioning This Company

17 Companies Building the Future of Drug Development on a Chip

In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate the structure and function of human organs in a laboratory setting. Donald E. Ingber, a bioengineer at Harvard University, was a key early player in this field, developing the first …